"New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis
- PMID: 16054078
- DOI: 10.1016/j.cmet.2005.04.002
"New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis
Abstract
De novo lipogenesis is an energy-expensive process whose role in adult mammals is poorly understood. We generated mice with liver-specific inactivation of fatty-acid synthase (FAS), a key lipogenic enzyme. On a zero-fat diet, FASKOL (FAS knockout in liver) mice developed hypoglycemia and fatty liver, which were reversed with dietary fat. These phenotypes were also observed after prolonged fasting, similarly to fasted PPARalpha-deficiency mice. Hypoglycemia, fatty liver, and defects in expression of PPARalpha target genes in FASKOL mice were corrected with a PPARalpha agonist. On either zero-fat or chow diet, FASKOL mice had low serum and hepatic cholesterol levels with elevated SREBP-2, decreased HMG-CoA reductase expression, and decreased cholesterol biosynthesis; these were also corrected with a PPARalpha agonist. These results suggest that products of the FAS reaction regulate glucose, lipid, and cholesterol metabolism by serving as endogenous activators of distinct physiological pools of PPARalpha in adult liver.
Similar articles
-
Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.Eur J Gastroenterol Hepatol. 2008 Sep;20(9):843-54. doi: 10.1097/MEG.0b013e3282f9b203. Eur J Gastroenterol Hepatol. 2008. PMID: 18794597
-
A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver.Biochem J. 2005 Jul 15;389(Pt 2):413-21. doi: 10.1042/BJ20041896. Biochem J. 2005. PMID: 15777286 Free PMC article.
-
Down-regulation in muscle and liver lipogenic genes: EPA ethyl ester treatment in lean and overweight (high-fat-fed) rats.J Nutr Biochem. 2009 Sep;20(9):705-14. doi: 10.1016/j.jnutbio.2008.06.013. Epub 2008 Sep 30. J Nutr Biochem. 2009. PMID: 18829285
-
Regulation of genes involved in lipid metabolism by dietary oxidized fat.Mol Nutr Food Res. 2011 Jan;55(1):109-21. doi: 10.1002/mnfr.201000424. Epub 2010 Nov 18. Mol Nutr Food Res. 2011. PMID: 21207516 Review.
-
SREBP transcription factors: master regulators of lipid homeostasis.Biochimie. 2004 Nov;86(11):839-48. doi: 10.1016/j.biochi.2004.09.018. Biochimie. 2004. PMID: 15589694 Review.
Cited by
-
The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation.J Nutr Biochem. 2021 Sep;95:108633. doi: 10.1016/j.jnutbio.2021.108633. Epub 2021 Mar 28. J Nutr Biochem. 2021. PMID: 33789150 Free PMC article. Review.
-
Fatty acid-regulated transcription factors in the liver.Annu Rev Nutr. 2013;33:249-69. doi: 10.1146/annurev-nutr-071812-161139. Epub 2013 Mar 22. Annu Rev Nutr. 2013. PMID: 23528177 Free PMC article. Review.
-
RGC-32 Deficiency Protects against Hepatic Steatosis by Reducing Lipogenesis.J Biol Chem. 2015 Aug 14;290(33):20387-95. doi: 10.1074/jbc.M114.630186. Epub 2015 Jul 1. J Biol Chem. 2015. PMID: 26134570 Free PMC article.
-
Fluoxetine regulates glucose and lipid metabolism via the PI3K‑AKT signaling pathway in diabetic rats.Mol Med Rep. 2020 Oct;22(4):3073-3080. doi: 10.3892/mmr.2020.11416. Epub 2020 Aug 4. Mol Med Rep. 2020. PMID: 32945450 Free PMC article.
-
The Fatty Acid Synthase Inhibitor Platensimycin Improves Insulin Resistance without Inducing Liver Steatosis in Mice and Monkeys.PLoS One. 2016 Oct 3;11(10):e0164133. doi: 10.1371/journal.pone.0164133. eCollection 2016. PLoS One. 2016. PMID: 27695056 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous